Company: MVNC
Filing Date: 2025-01-21
Form Type: DEF 14C
Source: 0001683168-25-000446
Chunk: 3

Company: Marvion Inc.
Filing Date: 2025-01-21
Form: DEF 14C
Chunk 3
---
 as adopted by the Board                                           
 on December 28, 2024. The 2023 Plan Amendment relates to an increase in the number of shares of Common Stock of the Company remaining 
 for issuance under the 2023 Plan by 31,408,394 shares of Common Stock.                                                                |
| 5. | To consider and act on an advisory (non-binding) proposal on the compensation arrangements of certain                                 
 executive officers; and                                                                                                               |
| 6. | To consider and act on an advisory (non-binding) proposal on how frequently stockholders should vote to                               
 approve the compensation arrangements of certain executive officers.                                                                  |

This Information Statement is being sent to you to
notify you of the Corporate Actions being taken by written consent in lieu of a meeting of our stockholders. On December 28, 2024, our
Board adopted and approved the Corporate Actions. The information statement is being delivered only to inform you of the Corporate Actions
described herein before such actions take effect in accordance with Rule 14c-2 promulgated under the Securities Exchange Act of 1934,
as amended (the “Exchange Act”). No action is requested or required on your part.

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.

THIS IS NOT A NOTICE OF A MEETING OF STOCKHOLDERS
AND NO STOCKHOLDERS’ MEETING WILL BE HELD TO CONSIDER ANY MATTER DESCRIBED HEREIN.

PLEASE NOTE THAT THE HOLDERS OF A MAJORITY OF OUR
OUTSTANDING SHARES OF COMMON STOCK HAVE VOTED TO AUTHORIZE THE CORPORATE ACTIONS. THE NUMBER OF VOTES RECEIVED IS SUFFICIENT TO SATISFY
THE STOCKHOLDER VOTE REQUIREMENT AND NO ADDITIONAL VOTES WILL CONSEQUENTLY BE NEEDED TO APPROVE THESE MATTERS.

| 1 |

<div align='center'>VOTING AND VOTE REQUIRED; EFFECTIVE DATE OF CORPORATE ACTIONS.</div>

Section 78.320 of Chapter 78 of
the NRS provides that the written consent of the holders of outstanding shares of voting capital stock having not less than the minimum
number of votes which would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were
present and voted can approve an action in lieu of conducting a special stockholders’ meeting convened for the specific purpose
of such action. The NRS, however, require that in the